Veracity Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Sell |
5,597
-4
| -0.1% | -$2.1K | 1.01% | 11 |
|
|
2025
Q1 | $3.55M | Sell |
5,601
-13
| -0.2% | -$8.25K | 1.38% | 8 |
|
|
2024
Q4 | $4M | Sell |
5,614
-58
| -1% | -$41.3K | 1.44% | 9 |
|
|
2024
Q3 | $5.96M | Sell |
5,672
-140
| -2% | -$147K | 2.26% | 7 |
|
|
2024
Q2 | $6.11M | Sell |
5,812
-310
| -5% | -$326K | 2.54% | 6 |
|
|
2024
Q1 | $5.89M | Sell |
6,122
-241
| -4% | -$232K | 2.29% | 7 |
|
|
2023
Q4 | $5.59M | Sell |
6,363
-104
| -2% | -$91.3K | 2.24% | 7 |
|
|
2023
Q3 | $5.32M | Sell |
6,467
-51
| -0.8% | -$42K | 2.47% | 5 |
|
|
2023
Q2 | $4.68M | Buy |
6,518
+17
| +0.3% | +$12.2K | 1.99% | 7 |
|
|
2023
Q1 | $5.34M | Sell |
6,501
-293
| -4% | -$241K | 2.47% | 7 |
|
|
2022
Q4 | $4.9M | Sell |
6,794
-145
| -2% | -$105K | 2.35% | 5 |
|
|
2022
Q3 | $4.78M | Buy |
6,939
+2
| +0% | +$1.38K | 2.6% | 6 |
|
|
2022
Q2 | $4.1M | Sell |
6,937
-110
| -2% | -$65K | 2.18% | 7 |
|
|
2022
Q1 | $4.92M | Sell |
7,047
-221
| -3% | -$154K | 2.04% | 7 |
|
|
2021
Q4 | $4.59M | Buy |
7,268
+37
| +0.5% | +$23.4K | 1.84% | 10 |
|
|
2021
Q3 | $4.38M | Sell |
7,231
-530
| -7% | -$321K | 1.88% | 8 |
|
|
2021
Q2 | $4.34M | Sell |
7,761
-8,009
| -51% | -$4.47M | 1.01% | 19 |
|
|
2021
Q1 | $7.46M | Sell |
15,770
-1,406
| -8% | -$665K | 1.59% | 10 |
|
|
2020
Q4 | $8.3M | Buy |
17,176
+792
| +5% | +$383K | 2.08% | 7 |
|
|
2020
Q3 | $9.17M | Buy |
16,384
+322
| +2% | +$180K | 2.5% | 4 |
|
|
2020
Q2 | $10M | Sell |
16,062
-174
| -1% | -$109K | 2.8% | 6 |
|
|
2020
Q1 | $7.93M | Sell |
16,236
-1,086
| -6% | -$530K | 2.29% | 10 |
|
|
2019
Q4 | $6.5M | Buy |
+17,322
| New | +$6.5M | 1.68% | 10 |
|